UpDoc Leads ARPA-H Program for Clinical AI Care
Palo Alto, California, U.S., September 9, 2026 UpDoc has been selected by the Advanced Research Projects Agency for Health...
ARPA-H
Advertisement
AstraZeneca’s Tozorakimab Cuts COPD Exacerbations in Phase 3
Cambridge, UK, September 8, 2026 AstraZeneca has reported detailed results from the Phase III OBERON and TITANIA trials showing...
NanoMosaic Advances Distributed Genetic Medicine Manufacturing
Waltham, Massachusetts, USA, September 8, 2026 NanoMosaic has joined a Mass General Brigham-led consortium selected for the Advanced Research...
Philips Wins $33.7M ARPA-H Award for Robotic Stroke Care
Cambridge, Massachusetts, United States & Amsterdam, Netherlands, Aug 26, 2026 Royal Philips has received an award of up to...
Dassault Systèmes Powers Virtual Twin Factories with AI Agents
VELIZY-VILLACOUBLAY, France, July 23, 2026 Dassault Systèmes has expanded its 3DEXPERIENCE AI-native agentic platform with the launch of three...
Advertisements
Apertura Joins ARPA-H Program for Rare Gene Therapies
NEW YORK, N.Y., July 23, 2026 Apertura Gene Therapy has announced its participation in a consortium selected to receive...
City of Hope Launches Phase 2 Lung Cancer Biomarker Trial
LOS ANGELES, July 21, 2026 City of Hope has launched the national Phase 2 IMMUNO-BIOMAP clinical trial to better...
Jackson Laboratory Wins ARPA-H Funding for Rare CNS Diseases
BAR HARBOR, Maine, USA, July 9, 2026 The Jackson Laboratory (JAX), in collaboration with the Broad Institute and a...
GEMMABio Receives ARPA-H Grant for Precision Gene Editing
PHILADELPHIA, Pennsylvania, USA, July 9, 2026 GEMMA Biotherapeutics (GEMMABio) has been awarded funding from the Advanced Research Projects Agency...
Sanofi Lunsekimig Shows Strong Phase 2 Results in Asthma
Paris, France, April 7, 2026 Phase 2 Success Across Respiratory Indications In a major advancement for respiratory disease therapeutics,...
Advertisement
